DNA-Nanoscaffold-Assisted Selection of Femtomolar Bivalent Human α-Thrombin Aptamers with Potent Anticoagulant Activity

Yu Zhou, Xiaodong Qi, Yan Liu, Fei Zhang, Hao Yan

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Multivalent aptamers that interact with their target proteins through multiple sites exhibit much stronger binding strengths than their monovalent counterparts. In this work, we have designed a single-stranded DNA (ssDNA) library (1015 molecules, each 145 nt) based on a predefined DNA nanostructure designed to present two random-loop sites for bivalent aptamer evolution. From this library, a group of ultra-strong bivalent aptamers against human α-thrombin (with apparent KD values of ≈340 fm) were easily identified through a simple seven-round conventional systematic evolution of ligands by exponential enrichment (SELEX) procedure. The dominant bivalent aptamers consist of two components, one binding to exosite I and the other to exosite II. The best of these bivalent aptamers show strong allosteric attenuation of the thrombin cleavage activity and also display an extremely potent anticoagulation effect in human plasma, demonstrating their great potential in therapeutic applications. The method developed here can easily be adapted to conventional SELEX techniques, opening a new route for fast selection of multivalent aptamers with superior binding affinity for other targets.

Original languageEnglish (US)
Pages (from-to)2494-2503
Number of pages10
JournalChemBioChem
Volume20
Issue number19
DOIs
StatePublished - Oct 1 2019
Externally publishedYes

Fingerprint

SELEX Aptamer Technique
Thrombin
Anticoagulants
Ligands
Plasma (human)
Nanostructures
Single-Stranded DNA
DNA
Gene Library
Libraries
Molecules
Proteins
thrombin aptamer
Therapeutics

Keywords

  • affinity
  • anticoagulation
  • aptamers
  • DNA structures
  • thrombin

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Organic Chemistry

Cite this

DNA-Nanoscaffold-Assisted Selection of Femtomolar Bivalent Human α-Thrombin Aptamers with Potent Anticoagulant Activity. / Zhou, Yu; Qi, Xiaodong; Liu, Yan; Zhang, Fei; Yan, Hao.

In: ChemBioChem, Vol. 20, No. 19, 01.10.2019, p. 2494-2503.

Research output: Contribution to journalArticle

@article{10ec1889446f4e51bb31f8c526cde8ef,
title = "DNA-Nanoscaffold-Assisted Selection of Femtomolar Bivalent Human α-Thrombin Aptamers with Potent Anticoagulant Activity",
abstract = "Multivalent aptamers that interact with their target proteins through multiple sites exhibit much stronger binding strengths than their monovalent counterparts. In this work, we have designed a single-stranded DNA (ssDNA) library (1015 molecules, each 145 nt) based on a predefined DNA nanostructure designed to present two random-loop sites for bivalent aptamer evolution. From this library, a group of ultra-strong bivalent aptamers against human α-thrombin (with apparent KD values of ≈340 fm) were easily identified through a simple seven-round conventional systematic evolution of ligands by exponential enrichment (SELEX) procedure. The dominant bivalent aptamers consist of two components, one binding to exosite I and the other to exosite II. The best of these bivalent aptamers show strong allosteric attenuation of the thrombin cleavage activity and also display an extremely potent anticoagulation effect in human plasma, demonstrating their great potential in therapeutic applications. The method developed here can easily be adapted to conventional SELEX techniques, opening a new route for fast selection of multivalent aptamers with superior binding affinity for other targets.",
keywords = "affinity, anticoagulation, aptamers, DNA structures, thrombin",
author = "Yu Zhou and Xiaodong Qi and Yan Liu and Fei Zhang and Hao Yan",
year = "2019",
month = "10",
day = "1",
doi = "10.1002/cbic.201900265",
language = "English (US)",
volume = "20",
pages = "2494--2503",
journal = "Chembiochem : a European journal of chemical biology",
issn = "1439-4227",
publisher = "Wiley-VCH Verlag",
number = "19",

}

TY - JOUR

T1 - DNA-Nanoscaffold-Assisted Selection of Femtomolar Bivalent Human α-Thrombin Aptamers with Potent Anticoagulant Activity

AU - Zhou, Yu

AU - Qi, Xiaodong

AU - Liu, Yan

AU - Zhang, Fei

AU - Yan, Hao

PY - 2019/10/1

Y1 - 2019/10/1

N2 - Multivalent aptamers that interact with their target proteins through multiple sites exhibit much stronger binding strengths than their monovalent counterparts. In this work, we have designed a single-stranded DNA (ssDNA) library (1015 molecules, each 145 nt) based on a predefined DNA nanostructure designed to present two random-loop sites for bivalent aptamer evolution. From this library, a group of ultra-strong bivalent aptamers against human α-thrombin (with apparent KD values of ≈340 fm) were easily identified through a simple seven-round conventional systematic evolution of ligands by exponential enrichment (SELEX) procedure. The dominant bivalent aptamers consist of two components, one binding to exosite I and the other to exosite II. The best of these bivalent aptamers show strong allosteric attenuation of the thrombin cleavage activity and also display an extremely potent anticoagulation effect in human plasma, demonstrating their great potential in therapeutic applications. The method developed here can easily be adapted to conventional SELEX techniques, opening a new route for fast selection of multivalent aptamers with superior binding affinity for other targets.

AB - Multivalent aptamers that interact with their target proteins through multiple sites exhibit much stronger binding strengths than their monovalent counterparts. In this work, we have designed a single-stranded DNA (ssDNA) library (1015 molecules, each 145 nt) based on a predefined DNA nanostructure designed to present two random-loop sites for bivalent aptamer evolution. From this library, a group of ultra-strong bivalent aptamers against human α-thrombin (with apparent KD values of ≈340 fm) were easily identified through a simple seven-round conventional systematic evolution of ligands by exponential enrichment (SELEX) procedure. The dominant bivalent aptamers consist of two components, one binding to exosite I and the other to exosite II. The best of these bivalent aptamers show strong allosteric attenuation of the thrombin cleavage activity and also display an extremely potent anticoagulation effect in human plasma, demonstrating their great potential in therapeutic applications. The method developed here can easily be adapted to conventional SELEX techniques, opening a new route for fast selection of multivalent aptamers with superior binding affinity for other targets.

KW - affinity

KW - anticoagulation

KW - aptamers

KW - DNA structures

KW - thrombin

UR - http://www.scopus.com/inward/record.url?scp=85072747347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072747347&partnerID=8YFLogxK

U2 - 10.1002/cbic.201900265

DO - 10.1002/cbic.201900265

M3 - Article

C2 - 31083763

AN - SCOPUS:85072747347

VL - 20

SP - 2494

EP - 2503

JO - Chembiochem : a European journal of chemical biology

JF - Chembiochem : a European journal of chemical biology

SN - 1439-4227

IS - 19

ER -